For instance, in breast cancers, the expression status of estrogen receptor α (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) can be used to guide treatment decisions [5]. This evidence concerns the gene ESR1 and breast carcinoma.